The electrophysiological and molecular effects of chronic β-adrenoceptor antagonist therapy on human atrium
The chronic treatment of patients with a β-adrenoceptor antagonist is associated with prolongation of the atrial cell action potential duration (APD), potentially contributing to the ability of these drugs to prevent atrial fibrillation (AF). The mechanisms underlying this APD prolongation are not f...
| Main Author: | |
|---|---|
| Published: |
University of Glasgow
2008
|
| Subjects: | |
| Online Access: | http://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.499556 |